Altered autonomic balance [ 63, 72], stress-axis dysfunction [ 73– 75], sensitised nervous system [ 76, 77] and activated inflammatory response [ 78] are all pathophysiological mechanisms that are believed to have the potential to produce and maintain physical symptoms.
To analyze whether human cathepsin B has the catalytic activity to produce bioactive IL-1β from pro-IL-1β to activate inflammatory responses in parenchymal cells (e.g., fibroblasts) such as caspase-1, we analyzed IκB degradation and NFκB phosphorylation in cells treated with pro-IL-1β after different processing.
It is widely accepted that TLR9 signaling mainly activates inflammatory responses, including proinflammatory cytokines [18], [21], [22], [38].
Of interest, structure-function studies revealed that the size and shape of the synthetic crystals influences their ability to activate inflammatory responses (e.g. nitric oxide, chemokine and cytokine mRNA) in vitro and in vivo.
Of interest, morphology-function studies reveal that the size and shape of the synthetic crystals (nanocrystalline, slow crystalline and rapid crystalline) influences their ability to activate inflammatory responses, as illustrated by differences in chemokine mRNA induction in vitro and in vivo and in the amplification of IFNγ-mediated NO production.
GIP has been shown to activate inflammatory responses in adipocytes by inducing secretion of inflammatory cytokines, chemokines, and proinflammatory nuclear factors (51).
Much interest is currently focused on the translocation of bacterial pathogen-associated molecular patterns (PAMPs), which activate inflammatory responses through Toll-like receptors (TLRs).
